검체 관리 시장 : 전략적 인사이트 및 예측(2026-2031년)

The Specimen Management Market is forecast to grow at a CAGR of 11.0%, reaching USD 9.64 billion in 2031 from USD 3.78 billion in 2026.

The global specimen management market is experiencing robust growth, driven by the increasing adoption of precision medicine, molecular diagnostics, and the expansion of biobanking activities. Specimen management encompasses technologies, consumables, software, and services that enable laboratories to collect, label, transport, store, monitor, and retrieve biological samples throughout their lifecycle. The market serves hospitals, diagnostic laboratories, pharmaceutical companies, biotechnology firms, contract research organizations, biobanks, and academic research institutions where specimen quality determines the reliability of downstream analytical results. Increasing molecular diagnostics, genomic testing, and personalized medicine programs are expanding demand for standardized specimen workflows because larger and more complex sample inventories require continuous traceability and controlled storage environments. Regulatory agencies continue emphasizing sample integrity, documentation accuracy, and data traceability, encouraging laboratories to replace manual processes with automated specimen management platforms. This evolution strengthens operational efficiency while supporting reproducible research, regulatory compliance, and high-quality patient care.

Market Drivers

Increasing Adoption of Precision Medicine and Molecular Diagnostics

• Precision medicine depends on accurate biological specimens that maintain integrity from collection through laboratory analysis. Healthcare providers are expanding genomic testing, companion diagnostics, and molecular pathology services because individualized treatment decisions require reliable biological data. Higher testing complexity increases the need for standardized specimen handling and continuous tracking throughout laboratory workflows. Manufacturers are developing integrated specimen management platforms that combine automated identification, storage, and traceability capabilities. This transition strengthens demand for advanced specimen management solutions across clinical diagnostics and research environments.

Expansion of Biobanking and Clinical Research Activities

• Biobanks support biomedical research by preserving biological specimens for long-term scientific investigation. Research organizations are increasing specimen collection because translational medicine, population health studies, and regenerative medicine require extensive biological repositories. Larger specimen inventories create operational pressure on manual storage and retrieval systems while increasing documentation requirements. Technology providers are expanding automated biobank management systems that improve storage efficiency and sample traceability. These developments reinforce sustained demand for advanced specimen management infrastructure.

Growing Laboratory Automation

• Laboratory automation improves efficiency by reducing manual intervention across specimen processing workflows. Diagnostic laboratories are implementing robotic handling systems because increasing sample volumes require faster turnaround without compromising quality. Manual specimen handling introduces risks related to misidentification, contamination, and workflow delays. Vendors are integrating automated specimen transport, storage, and tracking technologies with laboratory information systems to streamline operations. Automation strengthens laboratory productivity while improving specimen integrity throughout the testing lifecycle.

Increasing Regulatory Focus on Sample Traceability

• Healthcare and research laboratories operate within regulated environments where specimen traceability directly influences quality assurance and patient safety. Regulatory authorities continue strengthening expectations for documented chain of custody, standardized labeling, and validated storage conditions because biological specimens support diagnostic and therapeutic decision-making. Manual documentation limits audit readiness and increases compliance risks. Laboratories are adopting digital specimen management systems that provide electronic records, audit trails, and real-time inventory monitoring. Regulatory compliance therefore remains a significant driver of market expansion.

Market Restraints

• High implementation costs associated with automated storage systems, integrated software platforms, and laboratory infrastructure upgrades continue limiting adoption among smaller laboratories. Integration of specimen management platforms with legacy laboratory information systems and existing analytical equipment remains technically complex, increasing implementation timelines. Data security, system validation, and compliance requirements continue creating operational challenges for laboratories deploying cloud-based specimen management solutions.

Technology and Segment Insights

By Product Type

• Specimen collection kits form the foundation of specimen management because the quality of downstream laboratory analysis depends on proper sample collection and preservation. Healthcare providers are increasing adoption of standardized collection kits as molecular diagnostics and genomic analysis expand. Specimen transport systems ensure sample integrity during transit between collection sites and laboratories. Specimen storage systems, including refrigerators, freezers, and automated storage units, maintain sample viability for future testing. Specimen tracking systems and management software provide digital visibility and chain-of-custody documentation. Consumables and accessories support routine specimen handling operations.

By Technology

• Barcode technology remains the most widely adopted specimen tracking solution because it provides reliable identification while maintaining cost-effective implementation. RFID-based tracking offers enhanced automation and real-time visibility for high-value specimens. Laboratory Information Management System (LIMS) integration enables seamless data flow between specimen management and laboratory workflows. Automated specimen handling systems, including robotic storage and retrieval, improve efficiency in high-volume laboratories. Cloud-based specimen management platforms are gaining adoption for multi-site laboratory networks requiring centralized visibility and standardized workflows.

By Application

• Clinical diagnostics represents the largest application segment because accurate specimen management directly influences patient diagnosis and treatment decisions. Hospitals and diagnostic laboratories are processing increasing numbers of biological specimens as chronic diseases and molecular testing continue expanding. Biobanking is a significant and growing application, supporting long-term storage for research. Drug discovery and development, clinical trials, genomics and precision medicine, pathology laboratories, and academic research studies represent additional applications driving demand for specialized specimen management solutions.

By End User

• Hospitals and health systems represent a major end-user segment, managing large volumes of clinical specimens. Clinical diagnostic laboratories require standardized specimen workflows for routine and specialized testing. Pharmaceutical and biotechnology companies utilize specimen management for drug development and research. Contract Research Organizations (CROs) need efficient specimen logistics for clinical trials. Biobanks require long-term storage and tracking solutions. Academic and research institutes utilize specimen management for various scientific investigations.

Competitive and Strategic Outlook

• The competitive landscape features major laboratory suppliers and specialized specimen management providers. Thermo Fisher Scientific Inc. distinguishes itself through its comprehensive laboratory workflow portfolio, combining specimen collection products, cold storage systems, automation, and informatics. Becton, Dickinson and Company (BD) differentiates itself through global leadership in specimen collection devices and preanalytical solutions. QIAGEN N.V. specializes in sample technologies supporting molecular diagnostics and genomics. Azenta Life Sciences maintains a strong position through specialized expertise in automated biobanking and biological sample storage. Hamilton Company and Tecan Group Ltd. provide advanced laboratory automation technologies. Greiner Bio-One International GmbH offers a strong portfolio of specimen collection products and consumables. LabVantage Solutions, Inc. provides enterprise laboratory informatics integrating specimen management.
• Strategic developments include increasing integration of artificial intelligence and digital tracking, expansion of automated biobanking infrastructure, and development of cloud-connected laboratory ecosystems. Companies are forming partnerships to enhance interoperability between specimen management platforms and other laboratory systems. Product launches focus on automated storage solutions, RFID tracking systems, and integrated software platforms. Companies that successfully combine automated hardware, intelligent software, and regulatory expertise are expected to maintain competitive leadership.

Conclusion

• The specimen management market is poised for significant growth, driven by the increasing adoption of precision medicine, expansion of biobanking, and laboratory automation. The evolution from standalone storage solutions toward integrated digital ecosystems supporting the entire specimen lifecycle is reshaping the market. Companies that successfully deliver automated, traceable, and compliant specimen management solutions are expected to lead the market. Ongoing technological innovation, regulatory support, and expanding research infrastructure across emerging economies will further accelerate adoption throughout the forecast period.

Key Benefits of this Report

• Insightful Analysis: Detailed market insights across regions, customer segments, policies, socio-economic factors, consumer preferences, and industry verticals.
• Competitive Landscape: Understand strategic moves by key players to identify optimal market entry approaches.
• Market Drivers and Future Trends: Assess major growth forces and emerging developments shaping the market.
• Actionable Recommendations: Support strategic decisions to unlock new revenue streams.
• Caters to a Wide Audience: Suitable for startups, research institutions, consultants, SMEs, and large enterprises.

What Businesses Use Our Reports For

• Industry and market insights, opportunity assessment, product demand forecasting, market entry strategy, geographical expansion, capital investment decisions, regulatory analysis, new product development, and competitive intelligence.

Report Coverage

• Historical data from 2021 to 2024, Base year 2025, and Forecast years from 2026 to 2031
• Growth opportunities, challenges, supply chain outlook, regulatory framework, and trend analysis
• Competitive positioning, strategies, and market share evaluation, and trade analysis
• Revenue growth and forecast assessment across segments and regions
• Company profiling including strategies, products, financials, and key developments

TABLE OF CONTENTS

1. Executive Summary

• 1.1 Market Snapshot
• 1.2 Key Findings
• 1.3 Analyst Insights
• 1.4 Strategic Recommendations

2. Research Methodology

• 2.1 Research Design
• 2.2 Data Collection Methodology
• 2.3 Market Size Estimation
• 2.4 Forecasting Model
• 2.5 Assumptions & Limitations

3. Specimen Management Market Overview, Size & Forecast

• 3.1 Market Definition & Scope
• 3.2 Industry Overview
• 3.3 Industry Evolution
• 3.4 Key Market Trends
• 3.5 Historical Market Size Analysis (2021-2025)
• 3.6 Market Forecast (2026-2031)
• 3.7 Laboratory Specimen Workflow Overview
• 3.8 Sample Traceability & Chain of Custody Analysis
• 3.9 Biobanking & Biospecimen Management Trends
• 3.10 Laboratory Automation Adoption Analysis
• 3.11 Digital Specimen Lifecycle Management

4. Market Dynamics

• 4.1 Market Drivers
• 4.2 Market Restraints
• 4.3 Market Opportunities
• 4.4 Market Challenges

5. Industry Landscape

• 5.1 Industry Value Chain Analysis
• 5.2 Pricing Analysis
• 5.3 Laboratory Workflow Optimization Analysis
• 5.4 Biobanking & Clinical Research Ecosystem Analysis

6. Innovation Landscape

• 6.1 Emerging Technologies
• 6.2 Product Innovation
• 6.3 AI Integration in Specimen Management
• 6.4 Laboratory Automation & Robotics Integration
• 6.5 RFID & Barcode-Based Tracking Technologies
• 6.6 Cloud-Based Specimen Management Solutions

7. Regulatory Landscape

• 7.1 Regulatory Framework
• 7.2 Sample Handling & Storage Standards
• 7.3 Compliance Requirements

8. Specimen Management Market Landscape Analysis

• 8.1 Analysis by Product Type
• 8.2 Analysis by Technology
• 8.3 Analysis by Application
• 8.4 Analysis by End User
• 8.5 Analysis by Workflow Stage

9. Specimen Management Market Segment Analysis (2021-2031)

• 9.1 By Product Type
  • 9.1.1 Specimen Collection Kits
  • 9.1.2 Specimen Transport Systems
  • 9.1.3 Specimen Storage Systems
  • 9.1.4 Specimen Tracking Systems
  • 9.1.5 Specimen Management Software
  • 9.1.6 Consumables & Accessories
• 9.2 By Technology
  • 9.2.1 Barcode-Based Tracking
  • 9.2.2 RFID-Based Tracking
  • 9.2.3 Laboratory Information Management System (LIMS) Integration
  • 9.2.4 Automated Specimen Handling Systems
  • 9.2.5 Cloud-Based Specimen Management Platforms
• 9.3 By Application
  • 9.3.1 Clinical Diagnostics
  • 9.3.2 Biobanking
  • 9.3.3 Drug Discovery & Development
  • 9.3.4 Clinical Trials
  • 9.3.5 Genomics & Precision Medicine
  • 9.3.6 Pathology Laboratories
  • 9.3.7 Academic & Research Studies
• 9.4 By End User
  • 9.4.1 Hospitals & Health Systems
  • 9.4.2 Clinical Diagnostic Laboratories
  • 9.4.3 Pharmaceutical & Biotechnology Companies
  • 9.4.4 Contract Research Organizations (CROs)
  • 9.4.5 Biobanks
  • 9.4.6 Academic & Research Institutes

10. Specimen Management Market Geographical Analysis (2021-2031)

• 10.1 North America
• 10.2 Europe
• 10.3 Asia-Pacific
• 10.4 South America
• 10.5 Middle East & Africa

11. Specimen Management Market Country Analysis (2021-2031)

• 11.1 United States
• 11.2 Canada
• 11.3 Germany
• 11.4 United Kingdom
• 11.5 France
• 11.6 Italy
• 11.7 Spain
• 11.8 Netherlands
• 11.9 Switzerland
• 11.10 China
• 11.11 Japan
• 11.12 India
• 11.13 South Korea
• 11.14 Australia
• 11.15 Brazil
• 11.16 Saudi Arabia
• 11.17 South Africa

12. Competitive Landscape

• 12.1 Market Share Analysis
• 12.2 Strategic Developments
• 12.3 Mergers & Acquisitions, Partnerships & Collaborations
• 12.4 Product Launches

13. Company Profiles

• 13.1 Thermo Fisher Scientific Inc.
• 13.2 Becton, Dickinson and Company (BD)
• 13.3 QIAGEN N.V.
• 13.4 Azenta Life Sciences
• 13.5 Hamilton Company
• 13.6 Tecan Group Ltd.
• 13.7 Brooks Automation (Azenta)
• 13.8 Avantor, Inc.
• 13.9 Corning Incorporated
• 13.10 Greiner Bio-One International GmbH
• 13.11 TrakCel Ltd.
• 13.12 LabVantage Solutions, Inc.
• 13.13 LabWare Inc.
• 13.14 Ziath Ltd.
• 13.15 SPT Labtech Ltd.

14. Specimen Management Market Commercial Forecast Analysis

• 14.1 Specimen Collection Systems
• 14.2 Automated Specimen Storage Systems
• 14.3 Specimen Tracking Solutions
• 14.4 Biobank Specimen Management Platforms
• 14.5 Clinical Trial Specimen Management Solutions
• 14.6 Integrated LIMS-Based Specimen Management Systems
• 14.7 AI-Enabled Specimen Workflow Solutions

15. Investment & Funding Analysis

• 15.1 Venture Capital Trends
• 15.2 Government Funding for Biobanking & Laboratory Infrastructure
• 15.3 R&D Investments

16. Future Outlook

• 16.1 Key Growth Opportunities
• 16.2 Future Industry Trends